JARID2 Antikörper (AA 1097-1246)
-
- Target Alle JARID2 Antikörper anzeigen
- JARID2 (Jumonji, AT Rich Interactive Domain 2 (JARID2))
-
Bindungsspezifität
- AA 1097-1246
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser JARID2 Antikörper ist unkonjugiert
-
Applikation
- ELISA, Immunocytochemistry (ICC), Flow Cytometry (FACS)
- Verwendungszweck
- JARID2 Antibody
- Aufreinigung
- Purified antibody
- Immunogen
- Purified recombinant fragment of human JARID2 (AA: 1097-1246) expressed in E. Coli.
- Klon
- 7H1B3
- Isotyp
- IgG2a
-
-
- Applikationshinweise
-
ELISA: 1/10000
FCM: 1/200 - 1/400
ICC: 1/200 - 1/1000
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- Purified antibody in PBS with 0.05 % sodium azide.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
-
- Target
- JARID2 (Jumonji, AT Rich Interactive Domain 2 (JARID2))
- Andere Bezeichnung
- JARID2 (JARID2 Produkte)
- Hintergrund
-
Description: This gene encodes a Jumonji- and AT-rich interaction domain (ARID)-domain-containing protein. The encoded protein is a DNA-binding protein that functions as a transcriptional repressor. This protein interacts with the Polycomb repressive complex 2 (PRC2) which plays an essential role in regulating gene expression during embryonic development. This protein facilitates the recruitment of the PRC2 complex to target genes. Alternate splicing results in multiple transcript variants. Mutations in this gene are associated with chronic myeloid malignancies.
Aliases: JMJ
- Molekulargewicht
- 139kDa
- Gen-ID
- 3720
- HGNC
- 3720
- UniProt
- Q92833
- Pathways
- Chromatin Binding
-